Antje Enekwe

Sleeping problems in children with neurodevelopmental disorders from a patient's and families perspective.

Journal: Sleep medicine

Published: April 11, 2025

MR-proANP, a cardiovascular biomarker to predict late-onset preeclampsia and intrauterine growth restricted fetuses.

Journal: Pregnancy hypertension

Published: February 18, 2020

Afamin: an early predictor of preeclampsia.

Journal: Archives of gynecology and obstetrics

Published: May 14, 2018

Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.

Journal: Pregnancy hypertension

Published: February 05, 2018

Follistatin during pregnancy and its potential role as an ovarian suppressing agent.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: December 11, 2016

Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.

Journal: Archives of gynecology and obstetrics

Published: March 23, 2015

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: September 16, 2014

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.

Journal: Endocrine connections

Published: June 15, 2014

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.

Journal: Archives of gynecology and obstetrics

Published: February 19, 2014

Abdominal Access for Shoulder Dystocia as a Last Resort - a Case Report.

Journal: Geburtshilfe und Frauenheilkunde

Published: February 24, 2012

Sleeping problems in children with neurodevelopmental disorders from a patient's and families perspective.

Sleeping problems in children with neurodevelopmental disorders from a patient's and families perspective.

MR-proANP, a cardiovascular biomarker to predict late-onset preeclampsia and intrauterine growth restricted fetuses.

MR-proANP, a cardiovascular biomarker to predict late-onset preeclampsia and intrauterine growth restricted fetuses.

Afamin: an early predictor of preeclampsia.

Afamin: an early predictor of preeclampsia.

Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.

Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.

Follistatin during pregnancy and its potential role as an ovarian suppressing agent.

Follistatin during pregnancy and its potential role as an ovarian suppressing agent.

Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.

Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia.

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.

Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients.

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.

Abdominal Access for Shoulder Dystocia as a Last Resort - a Case Report.

Abdominal Access for Shoulder Dystocia as a Last Resort - a Case Report.

Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.

Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.